NDC 14335-171
Dobutamine
Dobutamine
Dobutamine is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hainan Poly Pharm. Co., Ltd.. The primary component is Dobutamine Hydrochloride.
| Product ID | 14335-171_f153e636-62ab-3b86-e053-2995a90a36c1 |
| NDC | 14335-171 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dobutamine |
| Generic Name | Dobutamine |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-06-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA216131 |
| Labeler Name | Hainan Poly Pharm. Co., Ltd. |
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 13 mg/mL |
| Pharm Classes | Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |